Literature DB >> 7455118

The evolution of white matter disease as seen on computed tomography.

D M Barnes, D R Enzmann.   

Abstract

The evolving computed tomographic (CT) findings in three patients with different types of dysmyelinating white matter diseases (Krabbe, Canavan, ketotic hyperglycinemia) are presented. Serial CT scans suggested that the abnormal, low density white matter, which is characteristic of many white matter diseases, is present for only a limited time, corresponding to active dys- or demyelination. The low density abnormality gives way to a nonspecific final common pathway manifested as severe atrophy on CT. Ventricular enlargement is accentuated in this form of atrophy which appears to be the final stage in a wide variety, if not all, of white matter diseases.

Entities:  

Mesh:

Year:  1981        PMID: 7455118     DOI: 10.1148/radiology.138.2.7455118

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  Leuko-araiosis: a reappraisal. I. CT studies.

Authors:  D Inzitari; M Mascalchi
Journal:  Ital J Neurol Sci       Date:  1990-06

2.  Adult metachromatic leukodystrophy with an unusual relapsing-remitting course.

Authors:  M Sadeh; A Kuritzky; E Ben-David; Y Goldhammer
Journal:  Postgrad Med J       Date:  1992-03       Impact factor: 2.401

3.  GM-2 gangliosidosis (Sandhoff's disease): two year follow-up by MRI.

Authors:  W Koelfen; M Freund; W Jaschke; S Koenig; C Schultze
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

4.  Computed tomography in late-onset metachromatic leucodystrophy.

Authors:  H I Schipper; D Seidel
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

5.  Dysmyelinating leukodystrophies: "LACK Proper Myelin".

Authors:  H P Hatten
Journal:  Pediatr Radiol       Date:  1991

6.  Globoid cell leukodystrophy: comparison of neuropathology with magnetic resonance imaging.

Authors:  A K Percy; G T Odrezin; P D Knowles; E Rouah; D D Armstrong
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.